BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26982031)

  • 1. Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma.
    Barbone D; Van Dam L; Follo C; Jithesh PV; Zhang SD; Richards WG; Bueno R; Fennell DA; Broaddus VC
    PLoS One; 2016; 11(3):e0150044. PubMed ID: 26982031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression.
    Barbone D; Cheung P; Battula S; Busacca S; Gray SG; Longley DB; Bueno R; Sugarbaker DJ; Fennell DA; Broaddus VC
    PLoS One; 2012; 7(12):e52753. PubMed ID: 23300762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.
    Phillips MM; Pavlyk I; Allen M; Ghazaly E; Cutts R; Carpentier J; Berry JS; Nattress C; Feng S; Hallden G; Chelala C; Bomalaski J; Steele J; Sheaff M; Balkwill F; Szlosarek PW
    Pharmacol Rep; 2023 Jun; 75(3):570-584. PubMed ID: 37010783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
    Kim S; Lee M; Song Y; Lee SY; Choi I; Park IS; Kim J; Kim JS; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2021 Apr; 40(1):127. PubMed ID: 33838671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.
    Locke M; Ghazaly E; Freitas MO; Mitsinga M; Lattanzio L; Lo Nigro C; Nagano A; Wang J; Chelala C; Szlosarek P; Martin SA
    Cell Rep; 2016 Aug; 16(6):1604-1613. PubMed ID: 27452468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification.
    Barnett SE; Kenyani J; Tripari M; Butt Z; Grosman R; Querques F; Shaw L; Silva LC; Goate Z; Marciniak SJ; Rassl DM; Jackson R; Lian LY; Szlosarek PW; Sacco JJ; Coulson JM
    Mol Cancer Res; 2023 May; 21(5):411-427. PubMed ID: 36669126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells.
    Yamashita T; Nagano K; Kanasaki S; Maeda Y; Furuya T; Inoue M; Nabeshi H; Yoshikawa T; Yoshioka Y; Itoh N; Abe Y; Kamada H; Tsutsumi Y; Tsunoda S
    Biochem Biophys Res Commun; 2012 Apr; 421(1):140-4. PubMed ID: 22497892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance.
    Huang HY; Wu WR; Wang YH; Wang JW; Fang FM; Tsai JW; Li SH; Hung HC; Yu SC; Lan J; Shiue YL; Hsing CH; Chen LT; Li CF
    Clin Cancer Res; 2013 Jun; 19(11):2861-72. PubMed ID: 23549872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models.
    Barbone D; Follo C; Echeverry N; Gerbaudo VH; Klabatsa A; Bueno R; Felley-Bosco E; Broaddus VC
    PLoS One; 2015; 10(8):e0134825. PubMed ID: 26284517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines.
    Kitazono-Saitoh M; Takiguchi Y; Kitazono S; Ashinuma H; Kitamura A; Tada Y; Kurosu K; Sakaida E; Sekine I; Tanabe N; Tagawa M; Tatsumi K
    Oncol Rep; 2012 Jul; 28(1):33-40. PubMed ID: 22562354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
    Nicholson LJ; Smith PR; Hiller L; Szlosarek PW; Kimberley C; Sehouli J; Koensgen D; Mustea A; Schmid P; Crook T
    Int J Cancer; 2009 Sep; 125(6):1454-63. PubMed ID: 19533750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy.
    Xiang X; Phung Y; Feng M; Nagashima K; Zhang J; Broaddus VC; Hassan R; Fitzgerald D; Ho M
    PLoS One; 2011 Jan; 6(1):e14640. PubMed ID: 21305058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression status of candidate genes in mesothelioma tissues and cell lines.
    Melaiu O; Melissari E; Mutti L; Bracci E; De Santi C; Iofrida C; Di Russo M; Cristaudo A; Bonotti A; Cipollini M; Garritano SI; Foddis R; Lucchi M; Pellegrini S; Gemignani F; Landi S
    Mutat Res; 2015 Jan; 771():6-12. PubMed ID: 25771974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization.
    Huang Z; Wang TS; Zhao YC; Zuo RJ; Deng WB; Chi YJ; Yang ZM
    Mol Cell Endocrinol; 2014 May; 388(1-2):20-31. PubMed ID: 24556046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums.
    Khokhar NZ; She Y; Rusch VW; Sirotnak FM
    Clin Cancer Res; 2001 Oct; 7(10):3199-205. PubMed ID: 11595715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma.
    Soini Y; Kahlos K; Puhakka A; Lakari E; Säily M; Pääkkö P; Kinnula V
    Br J Cancer; 2000 Oct; 83(7):880-6. PubMed ID: 10970689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53.
    Miyamoto T; Lo PHY; Saichi N; Ueda K; Hirata M; Tanikawa C; Matsuda K
    Sci Adv; 2017 May; 3(5):e1603204. PubMed ID: 28560349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-spheroids: What can they tell us about pancreatic ductal adenocarcinoma cell phenotype?
    Gagliano N; Sforza C; Sommariva M; Menon A; Conte V; Sartori P; Procacci P
    Exp Cell Res; 2017 Aug; 357(2):299-309. PubMed ID: 28571915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids.
    Ruppen J; Cortes-Dericks L; Marconi E; Karoubi G; Schmid RA; Peng R; Marti TM; Guenat OT
    Lab Chip; 2014 Mar; 14(6):1198-205. PubMed ID: 24496222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.